Diametica Therapeutics(DMTC)

Therapeutics company

1 Insight

Investment Insights

AI-generated insights about Diametica Therapeutics from various financial sources

Friday, September 5, 2025

Very Bullish

A 10% owner with a previously successful track record purchased over $11 million worth of stock, suggesting a high level of confidence in the company's future.